MRK Company Financial Information

Symbol Info
Merck & Company Inc. (new) (MRK)
Listed Symbol	MRK
Name	Merck & Company Inc. (new)
Share Info
Annual Info
Latest Fiscal Dividend Per Share	$1,99
Latest Fiscal Date	2018-12-31
Latest Fiscal Revenue	$42.294.000.000
Latest Fiscal EPS	$2.32
Price Info
21 Day Moving Average	$83,5362
21 Day EMA	$83,760480
50 Day Moving Average	$84,1134
50 Day EMA	$83,579290
200 Day EMA	$79,500640
200 Day Moving Average	79,980820
52 Week High	$87.35
52 Week Low	$66,10
52 Week Change	$26.737800
Alpha	0.006267
Beta	0.5346
Standard Deviation	0.049038
R2	0.140287
Periods	60
Share Information
10 Day Average Volume	6.768.098
20 Day Average Volume	7.854.986
30 Day Average Volume	8.174.661
50 Day Average Volume	8.221.005
Outstanding Shares	2.560.374.643
Float Shares	2.557.140.187
Percent Float	99,87%
Short Interest	17.982.757
Short Percent Float	0,70%
Short Interest Ratio	2,24
Short Date	2019-09-13
Holders
Institutions	3.664
Institute Holdings Date	2019-09-30
Institute Bought Previous 3 Months	90.230.086
Institute Holdings Percent	-
Institute Sold Previous 3 Months	177.152.108
Insider Holdings Date	2019-08-31
Insider Bought Previous 3 Months	19
Insider Holdings Percent	0,10%
Insider Sold Previous 3 Months	-
Insiders Shares Owned	3.234.456
Price Change
7 Day Price Change	$-0,6600037
7 Day Percent Change	-0,78%
21 Day Price Change	$-0,8200073
21 Day Percent Change	-0,96%
30 Day Price Change	$1,9674377
30 Day Percent Change	2,39%
Month To Date Price Change	$0,1600
Month To Date Percent	0,19%
90 Day Price Change	$3,874756
90 Day Percent Change	4,82%
Quarter To Date	$0,159996
Quarter To Date Percent	0,19%
180 Day Price Change	$5,553261
180 Day Percent Change	7,05%
200 Day Price Change	$3,076378
200 Day Percent Change	3,79%
Year To Date	$9,446220
Year To Date Percent	12,61%
Profile
Description	Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States.
Details
Issue Type	CS
Market Cap	$215.941.997.391
Sec Type	EQS
Auditor	PricewaterhouseCoopers LLP
Total Shares Outstanding	2.560.374.643
CEO	Kenneth C. Frazier
Employees	69.000
Last Audit	UE
Classification
CIK	0000310158
Industry	Drug Manufacturers
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)
Info
Address	2000 Galloping Hill Road Kenilworth, NJ 7033
Website	https://www.merck.com
Facisimile
Telephone	+1 908 740-4000
Email	investor_relations@merck.com
Key Ratios
Profitability
EBIT Margin	28,00
EBITDA Margin	36,9
Pre-Tax Profit Margin	20,6
Profit Margin Cont	21,70
Gross Margin	69,90
Profit Margin TOT	21,70
Income Statements
Revenue	$33.573.000.000
Revenue Per Share	$13,1125
Revenue 3 Years	$-1,85
Revenue 5 Years	$-1,85
Valuation Measures
PE Ratio	22,90
Enterprise Value	$235.014.337.447
Price To Sales	6,432014
Price To Free Cash	-86,5
PE High Last 5 Years	92,2
Price To Book	7,6
Price To Cash Flow	19,8
PE Low Last 5 Years	11,3
Price To Tangible Book	-39,9
Financial Strength
Total Debt To Equity	1,0
Int Coverage	14,9
Current Ratio	1,2
Leverage Ratio	3,3
Quick Ratio	0,8
Long Term Debt To Capital	0,45
Assets
Receivables Turnover	1,8
Invoice Turnover	2,40
Assets Turnover	0,20
Management Effectiveness
Return Assets	11,08
Return On Equity	31,12
Return On Capital	17,72
Dividends
Dividend 3 Years	$3,82
Dividend 5 Years	$3,06
Ex Dividend Date	2019-09-13 00:00:00.0
Dividend Rate	$2,20
Dividend Yield	2,61%
Payment Type	Cash

Kürzlich von Ihnen besucht

NYSE

MRK

Merck

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.